Dr. Subha Shankar Das

Dr. Subha Shankar Das
  • Experience:

    • 2011- 2012: Internship, MBBS
    • February 2012- September 2012: House Officer, Mediland Hospital and Research Centre, Silchar, Assam
    • 2011- 2013: Medical Officer, Uttar Narainpur PHC, Hailakandi, Assam
    • 2013-2014: Medical Officer, Thaligram PHC, Cachar, Assam
    • January 2015- November 2015: House Resident, Department of TB and Chest Medicine, Silchar Medical College and Hospital, Silchar, Assam
    • March 2016- May 2016: House Resident, Department of Urology, NEIGRIHMS, Shillong, Meghalaya
    • 2016-2019: DNB trainee for three years in the Department of Nuclear Medicine, Seth G. S. Medical College & K. E. M. Hospital, Parel, Mumbai, Maharashtra

Dr. Subha Shankar Das

MBBS, DNB, Senior Resident

Dr. Subha Shankar Das works a Senior Resident at the Nuclear Medicine Department at Fortis Memorial Research Institute, Gurgaon, Haryana INDIA.

Dr. Subha has a rich experience of 8 years in the Nuclear Medicine Therapy discipline.

He completed his MBBS on the year 2012 from the Silchar Medical College, Assam University and there on he moved to moved to work as a House Officer, Mediland Hospital and Research Centre, Silchar, Assam

And his last assignment before joining Fortis was as a DNB Trainee at the G.S. Medical College & K.E. M Hospital, Parel Mumbai, Maharashtra.

In these 8 years he developed a keen interest in managing patients with Hyperthyroidism with low dose of radio-iodine therapy.

Specialised Training

  • Radioiodine Therapy and other treatments for Thyroid Cancer.
  • M.B.B.S. from Silchar Medical College and Hospital, Assam University (2006- 2012)
  • Maharashtra Medical Council  Registration No.: 2019/09/6289 Date of certification: 25th of September, 2019
  • Primary DNB trainee in Nuclear Medicine from Seth G. S. Medical College and K. E. M. Hospital, Parel, Mumbai (10/05/2016- 26/05/2019). DNB Passed.
  • Experience with Gamma camera, SPECT-CT system and PET-CT system. 
  • Experience in managing patients with hyperthyroidism with low dose radio-iodine therapy.